Assets Held For Sale Assets Held For Sale

6 Months Ended

Jun. 30, 2017

Assets held for sale [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Assets Held for Sale

The Company classifies assets held for sale when management approves and commits to a formal plan of sale with the expectation the sale will be completed within one year. The net assets of the business held for sale are then recorded at the lower of their current carrying value or the fair market value, less costs to sell.

During the second quarter 2017, the Company committed to a plan to sell the Cambridge BioMarketing Group, LLC (“Cambridge”), a subsidiary within the Digital Media segment, as it was determined to be a non-core asset. This determination resulted in a reclassification of assets held for sale on the condensed consolidated balance sheet with a net carrying value of $29.8 million as of June 30, 2017.

The following table presents information related to the assets and liabilities that were classified as held for sale in our condensed consolidated balance sheets (in thousands):

	June 30, 2017
Cash	$	813
Accounts receivable, net	4,746
Prepaid expenses and other current assets	210
Property and equipment, net	472
Goodwill	17,815
Other intangible assets, net	11,405
Other assets	29
Total assets held for sale	$	35,490
Accounts payable and accrued expenses	$	562
Deferred income taxes, non current	5,064
Total liabilities held for sale	$	5,626

On July 12, 2017,in a cash transaction, the Company sold Cambridge. The Company is currently determining the financial impact to the statement of operations which will be recorded in the third quarter 2017 (see Note 18 - Subsequent Events). The Company does not expect a material gain or loss from this transaction.